Format

Send to

Choose Destination
Oncotarget. 2017 Feb 7;8(6):9783-9793. doi: 10.18632/oncotarget.14189.

Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.

Author information

1
Department of Medical Oncology, Cancer Hospital of Fudan University, Minhang Branch, Shanghai 200240, China.
2
General Surgery Department, General Surgery Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
3
General Surgery Department, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, China.

Abstract

Aberrant activation of beta-catenin/TCF is a hallmark of colon cancer. How the functions of nuclear localized beta-catenin are regulated is not fully understood. Here, it was found that FOXN3 (Forkhead box N3) was down-regulated in colon cancer tissues. Forced expression of FOXN3 inhibited the growth, migration and invasion of colon cancer cells, while knocking down the expression of FOXN3 promoted the growth, migration, invasion and metastasis of colon cancer cells. FOXN3 bind to beta-catenin and inhibited beta-catenin/TCF signaling by blocking the interaction between beta-catenin and TCF4. Taken together, these data demonstrated the suppressive roles of FOXN3 in the progression of colon cancer, and indicated that restoring the functions of FOXN3 would be a novel therapeutic strategy for colon cancer.

KEYWORDS:

FOXN3; beta-catenin/TCF signaling; cell growth and migration; colon cancer

PMID:
28039460
PMCID:
PMC5354770
DOI:
10.18632/oncotarget.14189
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center